A Phase 3, Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Project: Research

StatusActive
Effective start/end date7/11/19 → 6/11/24
View all
View less

Keywords

  • clinical trial
  • phase 3 study
  • treatment efficacy
  • Crohn's Disease